EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comment on: Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals

Akram Jalal

Rheumatology Advances in Practice · 06.11.2026

DOI: 10.1093/rap/rkag141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 06.11.2026. Verfasst von Akram Jalal. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Jalal, A. (2026). Comment on: Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals. Rheumatology Advances in Practice. https://doi.org/10.1093/rap/rkag141

Vancouver

Jalal A. Comment on: Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals. Rheumatology Advances in Practice. 2026. doi:10.1093/rap/rkag141

BibTeX
@article{Jalal2026,
  author = {Jalal, Akram},
  title = {Comment on: Primary care anti-cyclic citrullinated protein antibody testing for rheumatoid arthritis and accompanying pathway redesign reduces unnecessary referrals},
  journal = {Rheumatology Advances in Practice},
  year = {2026},
  doi = {10.1093/rap/rkag141}
}
Kostenlos starten →